Ovarian cancer

(Credit: Photo by Queenmoonlite Studio on Shutterstock)

In a Nutshell

  • Two in five women (40%) with ovarian cancer in England were diagnosed only after an emergency hospital admission, not through a planned route.
  • The youngest women, the oldest women, frailer women, and those in the poorest neighborhoods faced the highest risk of an emergency diagnosis.
  • Women diagnosed this way were only about one-third as likely to have early-stage, more treatable cancer.

An ovarian cancer diagnosis often does not begin with a doctor’s appointment or a planned referral. For a large share of women, it begins in a hospital emergency room.

A new study in the journal BMJ Oncology tracking more than 28,000 women across England found that about 40%, or two in five, learned they had ovarian cancer only after an emergency hospital admission. That share climbs even higher for the youngest women, the oldest women, those already in poor health, and those living in the most economically deprived neighborhoods.

Ovarian cancer ranks as the eighth most common cancer among women worldwide and causes more than 200,000 deaths a year. Part of what makes it so dangerous is that its warning signs, including bloating, abdominal pain, feeling full quickly, unexplained weight loss, and fatigue, look like dozens of milder, everyday conditions. Roughly one in two women visits a primary care doctor with at least one of these symptoms in any given year, which helps explain how easily the disease slips past early detection. By the time many women feel sick enough to head to the emergency room, the cancer has often already advanced.

Timing at diagnosis carried real weight. Women whose cancer surfaced through an emergency admission were only about one-third as likely to have early-stage disease as women diagnosed through planned routes, such as a family doctor’s referral. An earlier study cited by the authors found that women diagnosed through the emergency route were roughly five times more likely to die within a year than those caught earlier, a gap that shows how much the path to diagnosis can matter.

Who Faces the Highest Risk of an Emergency Ovarian Cancer Diagnosis

Researchers examined records from 28,204 women diagnosed with ovarian cancer in England between January 2017 and December 2021, drawing on the country’s national cancer registration data and NHS hospital admission records. That scale makes it one of the largest examinations of emergency ovarian cancer diagnosis to date.

Overall, 40.3% of women were diagnosed within 28 days of an emergency admission, but the rate swung widely depending on the woman. Among those aged 18 to 29, it reached 42.7%. Women in their 70s sat at about 41%, and those over 79 climbed to nearly 55%. Women in their 30s, 40s, and 50s fared somewhat better, though their rates still hovered around a third.

Frailty, a measure of how many health problems a person has built up over time, often through aging or chronic illness, stood out as one of the sharpest dividing lines. Among women counted as severely frail, 68.6% were diagnosed after an emergency admission. Among those with no recorded frailty, the figure was 29.2%. Even after accounting for age and other factors, severely frail women were nearly twice as likely to be diagnosed this way.

Infographic showing a common pathway to ovarian cancer diagnosis, from early symptoms and primary care visits to emergency hospital admission and diagnosis, based on a study of 28,204 women in England.
Infographic by StudyFinds
Where a Woman Lives Shapes Her Odds

Money and geography mattered too. Women living in England’s most economically deprived neighborhoods carried a 10% higher risk of being diagnosed after an emergency admission than women in the wealthiest areas, even after researchers adjusted for age, health status, and other factors.

That pattern is not unique to ovarian cancer. Similar results have shown up for colorectal cancer and several other types, in line with broader evidence of barriers to timely diagnosis in more deprived communities, from booking a doctor’s appointment to moving through referrals and diagnostic tests.

Later-Stage Cancer at the Point of Diagnosis

How advanced the cancer was at diagnosis differed sharply between the two groups. Among women diagnosed through an emergency admission, about 14% had early-stage cancer. Among those diagnosed through other routes, roughly 39% did. Emergency-route patients were also far more likely to have stage 4 disease, about 43% versus 21%, and less likely to have low- or moderate-grade tumors. Stage carries real consequences, since ovarian cancer caught early is far more treatable, while advanced disease leaves fewer options and worse survival odds.

Why Emergency Ovarian Cancer Diagnosis Rates Haven’t Budged

According to the authors, their results line up with earlier research on other cancer patients in England, a sign that the problem has not eased over time. To the authors’ knowledge, this is the first national study to map the full range of patient risk factors tied to emergency ovarian cancer diagnosis in England. Across the five-year window, 2020 saw a small uptick, with 42.5% of women diagnosed through the emergency route, a bump the study links to possible disruptions in healthcare access without pinning it on any single cause.

In November 2025, the National Ovarian Cancer Audit launched a national quality improvement initiative in England and Wales, aiming to get more treatment to women diagnosed through the emergency route. The authors argue that other countries need to act as well, since the patterns they found likely reach well beyond England.

Women most likely to receive an emergency ovarian cancer diagnosis are not scattered randomly across the population. They tend to be the youngest, the oldest, the sickest, and the poorest. Closing that gap will take more than awareness campaigns; it calls for targeted action aimed squarely at the groups most likely to be diagnosed only when it may already be too late.

Disclaimer: This article summarizes findings from a peer-reviewed study for general information and is not medical advice. The research describes patterns and associations across a large group of women; it does not establish cause and effect and cannot predict any individual’s risk or outcome. Anyone with symptoms or concerns about ovarian cancer should speak with a qualified healthcare professional. Data reflect women diagnosed in England between 2017 and 2021 and may not apply directly to other countries or healthcare systems.


Paper Notes

Limitations

This study drew entirely on routinely collected administrative hospital records, so it could not include information reported by patients themselves, such as which symptoms they had or how long they experienced them before seeking care. Cancer stage was missing for about 21% of patients and tumor grade for about 34%, along with frailty and comorbidity records for roughly 5%. Researchers used a statistical technique called multiple imputation to fill some of these gaps, but they note that relying on hospital data rather than clinical notes carries limits. Because the records could not capture what happened in primary care before an emergency admission, the analysis could not fully account for factors such as individual health-seeking behavior, access to a family doctor, and the performance of diagnostic services. The authors are clear that their results point to associations, not proven causes, and that more research is needed.

Funding and Disclosures

This work was carried out alongside the National Ovarian Cancer Audit, part of the National Cancer Audit Collaborating Centre (NATCAN) based at the Royal College of Surgeons of England. NATCAN is commissioned by the Healthcare Quality Improvement Partnership (HQIP) and funded by NHS England and the Welsh Government. According to the authors, neither the commissioner nor the funders played any role in the study’s design, data collection, analysis, interpretation, writing, or the decision to publish. The authors declared no competing interests. Data came from the National Disease Registration Service and are available through NHS England’s Data Access Request Service under the relevant data agreements.

Publication Details

Authors: Georgia Zachou, Rui Wu, Andrew Hutchings, Jan van der Meulen, Ipek Gurol-Urganci, Agnieszka Michael, Sudha Sundar

Journal: BMJ Oncology

Paper Title: Ovarian cancer diagnosis within 28 days after an emergency admission to hospital: national population-based study of patient risk factors and cancer characteristics using routinely collected data in England

DOI: 10.1136/bmjonc-2025-001053

Volume/Issue: Vol. 5, e001053 (2026)

About StudyFinds Analysis

Called "brilliant," "fantastic," and "spot on" by scientists and researchers, our acclaimed StudyFinds Analysis articles are created using an exclusive AI-based model with complete human oversight by the StudyFinds Editorial Team. For these articles, we use an unparalleled LLM process across multiple systems to analyze entire journal papers, extract data, and create accurate, accessible content. Our writing and editing team proofreads and polishes each and every article before publishing. With recent studies showing that artificial intelligence can interpret scientific research as well as (or even better) than field experts and specialists, StudyFinds was among the earliest to adopt and test this technology before approving its widespread use on our site. We stand by our practice and continuously update our processes to ensure the very highest level of accuracy. Read our AI Policy (link below) for more information.

Our Editorial Process

StudyFinds publishes digestible, agenda-free, transparent research summaries that are intended to inform the reader as well as stir civil, educated debate. We do not agree nor disagree with any of the studies we post, rather, we encourage our readers to debate the veracity of the findings themselves. All articles published on StudyFinds are vetted by our editors prior to publication and include links back to the source or corresponding journal article, if possible.

Our Editorial Team

Steve Fink

Editor-in-Chief

John Anderer

Associate Editor

Leave a Comment